Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Sciences and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
ABNT
ALVES-FERNANDES, Débora Kristina et al. Antitumoral activity of 4-nerolidylcathecol (4-NC) in naïve and vemurafenib-resistant melanoma cells. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 11 nov. 2024. , 2016APA
Alves-Fernandes, D. K., Faião-Flores, F., Sandri, S., Oliveira, É. A. de, Turato, W. M., Barros, S. B. de M., & Maria-Engler, S. S. (2016). Antitumoral activity of 4-nerolidylcathecol (4-NC) in naïve and vemurafenib-resistant melanoma cells. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Alves-Fernandes DK, Faião-Flores F, Sandri S, Oliveira ÉA de, Turato WM, Barros SB de M, Maria-Engler SS. Antitumoral activity of 4-nerolidylcathecol (4-NC) in naïve and vemurafenib-resistant melanoma cells. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 17 res. FCF030.[citado 2024 nov. 11 ]Vancouver
Alves-Fernandes DK, Faião-Flores F, Sandri S, Oliveira ÉA de, Turato WM, Barros SB de M, Maria-Engler SS. Antitumoral activity of 4-nerolidylcathecol (4-NC) in naïve and vemurafenib-resistant melanoma cells. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 17 res. FCF030.[citado 2024 nov. 11 ]